Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press Careers
Contact Us
Company Logo
Reports Store
Top 11 Hot Markets
NEW
 Biologics Hot Titles 2025
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare
Mega Trends
3D Printing 5G and 6G Technologies Advanced Analytics and Predictive Analytics Alternative Proteins (Plant-Based, Cultured Meat) Artificial Intelligence (AI) Autonomous Systems Augmented Reality (AR) and Virtual Reality (VR) Big Data Analytics
Blockchain, Cryptocurrencies and Decentralized Finance (DeFi) Biotechnology Cloud Computing Cybersecurity Digital Therapeutics Digitalization E-commerce and Digital Retail Edtech and E-Learning
Electric Mobility ESG (Environmental, Social, Governance) Investments Fintech (Digital Payments, Neobanking, Open Banking) Healthtech and Telehealth Industry 4.0 and 5.0 Internet of Things (IoT) Nanotechnology Precision Medicine and Genomics
Quantum Computing Regtech and Insurtech Robotics Smart Homes and Buildings Space Economy Sustainability Sustainable Consumer Products Wearable Technology
Market Intelligence Platform
About GMM Global Forecast
NEW
 Real Growth Rate Analysis Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal

2025 Roxadustat Market Dynamics: Comprehensive Analysis of Trends & Growth

29 Apr, 2025

The Roxadustat Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Roxadustat Market?

The Roxadustat market has seen significant growth lately. The market size is projected to increase from $6.44 billion in 2024 to $6.92 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Roxadustat Industry?

The Roxadustat Global Market Report 2025 predicts that by 2029, the Roxadustat market will have grown to a size of $9.16 billion, with a compound annual growth rate (CAGR) of 7.3%.

Download Your Free Sample of the 2025 Roxadustat Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Roxadustat Market?

The key drivers in the roxadustat market are:

• Ongoing research for new indications
• Rising demand for non-injectable anemia treatments
• Expanding reimbursement policies
• Increase in the geriatric population

Global Market Segmentation: Identifying Major Roxadustat Industry Segments

The roxadustat market covered in this report is segmented –
1) By Type: 20mg, 50mg
2) By Product Formulation: Oral Tablets
3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers
4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions Subsegments:
1) By 20mg: Oral Tablets, Injectable Formulations
2) By 50mg: Oral Tablets, Injectable Formulations

Pre-order the 2025 Roxadustat Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Roxadustat Market?

The key trends in the roxadustat market are:

• There is a shift towards oral anemia treatments in the Roxadustat market.
• The market is experiencing growing competition from alternative therapies.
• The expansion of licensing agreements is becoming more common.
• Investment in hypoxia-inducible factor research and a focus on patient-centric treatments is an up-and-coming trend.

Who Are the Top Competitors & Leading Players in the Roxadustat Market?

Major players in the roxadustat market are:

• AstraZeneca PLC
• Viatris Inc.
• Astellas Pharma Inc.
• Dr. Reddy's Laboratories Ltd.
• Hetero Drugs Limited
• Akebia Therapeutics Inc.
• Metrochem API Private Limited
• FibroGen Inc.
• AMI Lifesciences
• Lee Pharma Ltd.
• Faran Shimi Pharmaceutical Company
• Maithri Drugs Pvt. Ltd.
• Clearsynth Labs Ltd.
• Bal Pharma
• HEMA Pharmaceuticals Pvt. Ltd.
• Zhejiang Hengkang Pharmaceutical Co. Ltd.
• Kimia Biosciences Pvt. Ltd.
• Lewens Labs Pvt. Ltd.
• Hangzhou Longshine Bio-Tech Co. Ltd.
• GLR Innovations
• Suzhou Biosyntech Co. Ltd.
• Shanvr Life Sciences Pvt. Ltd.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the Roxadustat market in 2024